Coronavirus treatment: India approves Gilead's remdesivir for emergency use, says health ministry
- Remdesivir is the first drug to show improvement in COVID-19 patients in formal clinical trials
- India's COVID-19 count inched towards 2 lakh-mark
India has approved Gilead Sciences Inc's antiviral drug remdesivir for emergency use in treating COVID-19 patients, the Lav Agarwal, joint secretary in the health ministry said today.
Select your Category
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more